These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 32260039)

  • 1. Immunopathogenesis and therapeutic vaccine strategies for chronic hepatitis B virus infection.
    Michel ML
    Virologie (Montrouge); 2014 Feb; 18(1):25-33. PubMed ID: 32260039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B virus: from immunobiology to immunotherapy.
    Grimm D; Heeg M; Thimme R
    Clin Sci (Lond); 2013 Jan; 124(2):77-85. PubMed ID: 23013042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B immunopathogenesis and immunotherapy.
    Golsaz-Shirazi F; Shokri F
    Immunotherapy; 2016; 8(4):461-77. PubMed ID: 26973127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Highly Attenuated Vesicular Stomatitis Virus-Based Vaccine Platform Controls Hepatitis B Virus Replication in Mouse Models of Hepatitis B.
    Moshkani S; Chiale C; Lang SM; Rose JK; Robek MD
    J Virol; 2019 Mar; 93(5):. PubMed ID: 30541859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-cell therapy for chronic viral hepatitis.
    Bertoletti A; Tan AT; Koh S
    Cytotherapy; 2017 Nov; 19(11):1317-1324. PubMed ID: 28847469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunopathogenesis of Hepatitis B Virus.
    Tseng TC; Huang LR
    J Infect Dis; 2017 Nov; 216(suppl_8):S765-S770. PubMed ID: 29156047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current progress in the development of therapeutic vaccines for chronic hepatitis B virus infection.
    Ghasemi F; Rostami S; Ghayour-Mobarhan M; Meshkat Z
    Iran J Basic Med Sci; 2016 Jul; 19(7):692-704. PubMed ID: 27635192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy for Chronic Hepatitis B using HBsAg-based Vaccine Formulations: From Preventive Commercial Vaccines to Therapeutic Approach Julio Cesar Aguilar.
    Cesar Aguilar J; Y L
    Euroasian J Hepatogastroenterol; 2014; 4(2):92-97. PubMed ID: 29699355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review of Current and Potential Treatments for Chronic Hepatitis B Virus Infection.
    Tsai E
    Gastroenterol Hepatol (N Y); 2021 Aug; 17(8):367-376. PubMed ID: 34602899
    [No Abstract]   [Full Text] [Related]  

  • 10. Immune therapy including dendritic cell based therapy in chronic hepatitis B virus infection.
    Akbar SM; Horiike N; Onji M
    World J Gastroenterol; 2006 May; 12(18):2876-83. PubMed ID: 16718812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Present and future DNA vaccines for chronic hepatitis B treatment.
    Cova L
    Expert Opin Biol Ther; 2017 Feb; 17(2):185-195. PubMed ID: 27892722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virus-Like Vesicle-Based Therapeutic Vaccine Vectors for Chronic Hepatitis B Virus Infection.
    Reynolds TD; Buonocore L; Rose NF; Rose JK; Robek MD
    J Virol; 2015 Oct; 89(20):10407-15. PubMed ID: 26246574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review article: novel therapies for hepatitis B virus cure - advances and perspectives.
    Lin CL; Kao JH
    Aliment Pharmacol Ther; 2016 Aug; 44(3):213-22. PubMed ID: 27302653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunopathogenesis of HBV Infection.
    Wu J; Han M; Li J; Yang X; Yang D
    Adv Exp Med Biol; 2020; 1179():71-107. PubMed ID: 31741334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B Virus Immunopathology, Model Systems, and Current Therapies.
    Sandhu P; Haque M; Humphries-Bickley T; Ravi S; Song J
    Front Immunol; 2017; 8():436. PubMed ID: 28450868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New antiviral targets for innovative treatment concepts for hepatitis B virus and hepatitis delta virus.
    Durantel D; Zoulim F
    J Hepatol; 2016 Apr; 64(1 Suppl):S117-S131. PubMed ID: 27084032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmacytoid dendritic cells induce efficient stimulation of antiviral immunity in the context of chronic hepatitis B virus infection.
    Martinet J; Leroy V; Dufeu-Duchesne T; Larrat S; Richard MJ; Zoulim F; Plumas J; Aspord C
    Hepatology; 2012 Nov; 56(5):1706-18. PubMed ID: 22707082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term efficacy of continuing hepatitis B vaccination in infancy in two Gambian villages.
    Whittle HC; Maine N; Pilkington J; Mendy M; Fortuin M; Bunn J; Allison L; Howard C; Hall A
    Lancet; 1995 Apr; 345(8957):1089-92. PubMed ID: 7715343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B Virus-Related Hepatocellular Carcinoma: Pathogenic Mechanisms and Novel Therapeutic Interventions.
    Xu HZ; Liu YP; Guleng B; Ren JL
    Gastrointest Tumors; 2014 Aug; 1(3):135-45. PubMed ID: 26676160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrahepatic innate immune response pathways are downregulated in untreated chronic hepatitis B.
    Lebossé F; Testoni B; Fresquet J; Facchetti F; Galmozzi E; Fournier M; Hervieu V; Berthillon P; Berby F; Bordes I; Durantel D; Levrero M; Lampertico P; Zoulim F
    J Hepatol; 2017 May; 66(5):897-909. PubMed ID: 28043874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.